Financials • Specialty Insurers
$43.62 ▲ +0.79
(+1.85%)
MKT CAP: $2.83B • VOL: 798.4K
52W L $9 52W H $45
ROARABLE / RQD
C- • 61/100
PIOTROSKI
6 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$37
MEDIAN
$49
MEAN
$50
HIGH
$59
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE LIFE TAPE
LIFE // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $52.78 | $50.16 | 2025-02-14 | $39.69 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $54.96 | $51.47 | 2025-02-06 | $41.00 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $49.73 | $47.98 | 2025-01-29 | $41.88 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $44.49 | — | 2025-01-17 | $42.75 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $38.39 | $41.44 | 2025-01-09 | $38.82 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $51.91 | $45.36 | 2024-12-18 | $37.95 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $42.31 | $44.06 | 2024-12-04 | $40.57 | -4.3% | 48% | C |